The Role of Hypertension and Dyslipidaemia in the Progression of Diabetic Retinopathy in Type 2 Diabetes
Abstract
Rajesh Jain, Susanne Olejas, Ani Rashel Feh, Alexander Edwards, Ibina Abigo, Wioleta Zietek, Rachel Davies, Zoonifer Khan, Satrupa Ragoonanan, Nisha Benoy and Muhammad Iqbal
Despite the introduction of retinal laser photocoagulation and vitreoretinal surgery, diabetic retinopathy (DR) remains a significant source of sight disorders and blindness amongst individuals with Type 2 Diabetes Mellitus (T2DM) [1]. Visual impairment and blindness can add an additional burden to individuals with T2DM, thereby, affecting their quality of life and ability to self-manage their diabetes [2]. The number of people registered blind and those with moderate to severe sight complications due to DR rose from 0.2 million to 0.4 and 1.4 million to 2.6 million respectively between 1990 to 2015 [3].